CapStone Cuts Jazz Pharma (JAZZ) to Hold; Concerned with Likelihood That FDA Will Approve for JZP-6
Tweet Send to a Friend
CapStone downgrades Jazz Pharma (Nasdaq: JAZZ) from Buy to Hold, saying that the FDA will likely no approve the company's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
